LIVE NEWS UPDATE

Indian Pharma Live News

Latest pharmaceutical, regulatory, research and business developments from across India's pharma industry.

LIVE
🇮🇳 INDIAN NEWS
IndiatimesIndia’s pharma industry shift towards high-value drugs to boost demand for agrochemicals and specialty che.. - Indiatimes https://hrtoday.in/Emcure Pharmaceuticals Promotes Amarendra Kumar to Executive Vice President - https://hrtoday.in/ The Pharma LetterIndia’s push for more reliable drug manufacturing - The Pharma Letter ANI NewsAssam: Pharmacy Council of India holds state-level National Pharmacy Week celebration at ADBU - ANI News IndiatimesTop 10 chemical distribution companies in India in 2027 - Indiatimes Hyderabad MailEli Lilly’s proposed $1bn Hyderabad investment gets fresh push from Revanth Reddy - Hyderabad Mail BioSpectrum IndiaBiodeal Pharma receives New Drug Permission from CDSCO for indigenously developed Midazolam Nasal Spray - BioSpectrum India The HinduIndia, U.S. vow to jointly act against emerging drug threats - The Hindu Prop News TimePharmacy Council of India calls for coordinated action to tackle antimicrobial resistance - Prop News Time www.pib.gov.inProduction Linked Incentive Schemes have Strengthened India’s Pharmaceutical, Bulk Drugs and Medical Devices Manufacturing Ecosystem - www.pib.gov.in IndiatimesIndia’s pharma industry shift towards high-value drugs to boost demand for agrochemicals and specialty che.. - Indiatimes https://hrtoday.in/Emcure Pharmaceuticals Promotes Amarendra Kumar to Executive Vice President - https://hrtoday.in/ The Pharma LetterIndia’s push for more reliable drug manufacturing - The Pharma Letter ANI NewsAssam: Pharmacy Council of India holds state-level National Pharmacy Week celebration at ADBU - ANI News IndiatimesTop 10 chemical distribution companies in India in 2027 - Indiatimes Hyderabad MailEli Lilly’s proposed $1bn Hyderabad investment gets fresh push from Revanth Reddy - Hyderabad Mail BioSpectrum IndiaBiodeal Pharma receives New Drug Permission from CDSCO for indigenously developed Midazolam Nasal Spray - BioSpectrum India The HinduIndia, U.S. vow to jointly act against emerging drug threats - The Hindu Prop News TimePharmacy Council of India calls for coordinated action to tackle antimicrobial resistance - Prop News Time www.pib.gov.inProduction Linked Incentive Schemes have Strengthened India’s Pharmaceutical, Bulk Drugs and Medical Devices Manufacturing Ecosystem - www.pib.gov.in
LIVE UPDATES

Top Global Pharma News

Latest pharmaceutical, biotech and regulatory developments from leading global sources.

LIVE
TOP NEWS
Fierce Pharma Regulatory tracker: Lilly beats Novo to land China's 1st oral GLP-1 weight loss nod - Fierce Pharma The Pharma Letter What FDA and EMA now accept from real-world data - The Pharma Letter European Medicines Agency (EMA) EMA and FDA set common principles for AI in medicine development - European Medicines Agency (EMA) Pharmaceutical Executive Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry - Pharmaceutical Executive BioPharm International FDA and EMA Requirements Converge for Cell and Gene Therapy CMC, but GMP Gaps Persist - BioPharm International BigGo Finance Taiwan's TAHO Pharmaceuticals' Antithrombotic Oral Film Clears FDA Acceptance Hurdle, Targets World's Second-Largest Drug Market - BigGo Finance HDBuzz SOM3355 Moves Toward Phase 3 as Both EMA and FDA Signal Support - HDBuzz Business Wire Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T) - Business Wire EurekAlert! ARDD 2026 brings global pharma, FDA leaders and longevity science pioneers to Harvard October 1–3 - EurekAlert! Reuters Upheaval at FDA pushes some biotech firms to move early trials out of US - Reuters Fierce Pharma Regulatory tracker: Lilly beats Novo to land China's 1st oral GLP-1 weight loss nod - Fierce Pharma The Pharma Letter What FDA and EMA now accept from real-world data - The Pharma Letter European Medicines Agency (EMA) EMA and FDA set common principles for AI in medicine development - European Medicines Agency (EMA) Pharmaceutical Executive Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry - Pharmaceutical Executive BioPharm International FDA and EMA Requirements Converge for Cell and Gene Therapy CMC, but GMP Gaps Persist - BioPharm International BigGo Finance Taiwan's TAHO Pharmaceuticals' Antithrombotic Oral Film Clears FDA Acceptance Hurdle, Targets World's Second-Largest Drug Market - BigGo Finance HDBuzz SOM3355 Moves Toward Phase 3 as Both EMA and FDA Signal Support - HDBuzz Business Wire Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T) - Business Wire EurekAlert! ARDD 2026 brings global pharma, FDA leaders and longevity science pioneers to Harvard October 1–3 - EurekAlert! Reuters Upheaval at FDA pushes some biotech firms to move early trials out of US - Reuters

Addvertisement

Editorial

Rare disease drug reviews need a credible reset
Editorial
Current Article

Rare disease drug reviews need a credible reset

Author: Editorial Board
Published: October 21, 2026 • 6:44 pm
The FDA’s rare-disease review initiative could make drug development more predictable and responsive to patients’ unmet needs. VoP’s view: Greater regulatory flexibility must come with rigorous evidence, transparent decisions, and strong safety and quality standards.
Read Full Article →
History

Expert Opinion

AI Assisted Contamination Assessment in Pharmaceutical Microbiology
Expert Opinion
Current Article

AI Assisted Contamination Assessment in Pharmaceutical Microbiology

Author: Mrs. Reeta Nauriyal
Published: October 10, 2026 • 2:38 pm
This article explores how artificial intelligence can support contamination assessment, colony detection, and environmental monitoring in pharmaceutical microbiology. It highlights the need for validated methods, reliable data, and microbiologist oversight to strengthen quality control and protect product quality.
Read Full Article →
History
History 1
No history article available
More Expert Opinion articles will appear here automatically when published.
History 2
No history article available
More Expert Opinion articles will appear here automatically when published.
History 3
No history article available
More Expert Opinion articles will appear here automatically when published.

Guest Article

History
History 1
No history article available
More Guest Article articles will appear here automatically when published.
History 2
No history article available
More Guest Article articles will appear here automatically when published.
History 3
No history article available
More Guest Article articles will appear here automatically when published.

Other

Pharmaceutical Billing and HSN Classification
Other
Current Article

Pharmaceutical Billing and HSN Classification

Author: Mr. Deepak Kumar
Published: October 10, 2026 • 3:58 pm
This article examines common HSN classification and billing problems in the pharmaceutical industry, including GST mismatches, pricing errors, and expired-stock returns. It outlines practical solutions through verified product records, controlled tax updates, accurate invoicing, and regular reconciliation.
Read Full Article →
History
History 1
No history article available
More Other articles will appear here automatically when published.
History 2
No history article available
More Other articles will appear here automatically when published.
History 3
No history article available
More Other articles will appear here automatically when published.

Top-Category News Display

Vacancies In Pharma

The Story Behind Voice of Pharma

01

But its stories are scattered.

Voice of Pharma brings them together. We unify global and domestic pharmaceutical intelligence into a single curated destination.

Research Innovation Startups Regulation Journals Tech
Scattered pharma information unified
02

We don’t compete for every story.

We connect the stories, respect the original sources, and ensure that every authentic voice in the industry gets the recognition it deserves.

Connecting voices and respecting sources
1000+
Curated Intelligence
Global & domestic sources tracked daily
24+
Industry Pillars
Research, Startups, Regulation, Policy, Journals, Tech
100%
Original Attribution
Integrity & source respect guaranteed

Meet Our Experts

Julia Naroz
Front Face

Julia Naroz

Front Face
Bharadhawaj Mukesh
News & Media Coverage

Bharadhawaj Mukesh

News & Media Coverage
Amrit Dubey
Camera & Mice Expert

Amrit Dubey

Camera & Mice Expert
Mrs. Priya Devi
Editor in Chief Digital Media

Mrs. Priya Devi

Editor in Chief Digital Media
Mrs. Shalini Bisht
Pharma & Consultant

Mrs. Shalini Bisht

Pharma & Consultant
Mr. Roopesh Sachan
Behind the Curtain

Mr. Roopesh Sachan

Behind the Curtain
Voice of Pharma ecosystem
Discover • Connect • Appreciate • Credit • Create

One Pharma World. Many Voices. One Place.

[vop_live_chat]